Form 4 for ACHV ACHIEVE LIFE SCIENCES, INC.
Accepted 2023-04-24 00:00:00 ET · period of report 2023-04-21 · accession 0001209191-23-025380 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-04-24 | 2023-04-21 | ACHV | Bencich John | CEO, Dir | M - OptEx | $0.00 | +25.0K | 61.9K | +68% | $0 |
| D | 2023-04-24 | 2023-04-21 | ACHV | Bencich John | CEO, Dir | F - Tax | $6.80 | -7,324 | 54.6K | -12% | -$49.8K |
| D | 2023-04-24 | 2023-04-21 | ACHV | Bencich John | CEO, Dir | M - OptEx | $0.00 | +25.0K | 25.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-04-21 | M | A | 25,000 | $0.00 | 61,920 | D | — | — | (F1) Represents shares of common stock acquired upon settlement of the performance restricted stock units ("PRSUs") listed in Table II. |
| 2 | Common | Common Stock | 2023-04-21 | F | D | 7,324 | $6.80 | 54,596 | D | — | — | (F2) Represents shares of common stock that have been withheld by the issuer to satisfy the tax liability in connection with the settlement of PRSUs. |
| 3 | Derivative | Performance Restricted Stock Unit (PRSU) | 2023-04-21 | M | A | 25,000 | $0.00 | 25,000 | D | — · — to 2026-01-03 | 25,000 Common Stock | (F3) Each PRSU represents a contingent right to receive one share of the issuer's common stock at settlement. (F4) Pursuant to the terms of the PRSU 50% of the total shares underlying the PRSU vest on the achievement of a performance-based milestone, and 50% vest on the first anniversary of the achievement of such milestone. |